找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Radiation Therapy in Hematologic Malignancies; An Illustrated Pract Bouthaina Shbib Dabaja,Andrea K. Ng Book 2017 Springer International Pu

[復(fù)制鏈接]
樓主: Gullet
21#
發(fā)表于 2025-3-25 05:06:11 | 只看該作者
22#
發(fā)表于 2025-3-25 08:32:15 | 只看該作者
23#
發(fā)表于 2025-3-25 14:12:24 | 只看該作者
24#
發(fā)表于 2025-3-25 18:12:57 | 只看該作者
25#
發(fā)表于 2025-3-25 23:17:11 | 只看該作者
26#
發(fā)表于 2025-3-26 01:07:24 | 只看該作者
Radiation Therapy in the Management of Cutaneous T-Cell Lymphomas, Radiation therapy (RT) is an important palliative treatment modality in both advanced and localized cases. In this chapter, patients with advanced and early stage MF and pcALCL will be discussed. RT management in each of these cases will be addressed.
27#
發(fā)表于 2025-3-26 05:23:55 | 只看該作者
Extranodal Marginal Zone Lymphoma,tic strategies, with a special focus on the role of radiotherapy. Current recommendations in terms of optimal dose, volumes, and techniques are also presented. Few tables summarize the results of the largest series reporting on the outcome following radiotherapy, and figures illustrate imaging features as well as contouring and planning examples.
28#
發(fā)表于 2025-3-26 09:49:49 | 只看該作者
29#
發(fā)表于 2025-3-26 14:59:38 | 只看該作者
Extranodal Marginal Zone Lymphoma,ing virtually any organ, poses several challenges. The heterogeneity of the disease also explains the uncertainty and lack of consistency in radiotherapy approaches between centers and clinicians. EN-MZL often presents with localized/organ-confined disease, and RT is generally the primary curative m
30#
發(fā)表于 2025-3-26 17:36:48 | 只看該作者
Primary Mediastinal (Thymic) Large B-Cell Lymphoma,es that differ from diffuse large B-cell lymphoma (DLBCL). In the era of immunochemotherapy, a variety of chemotherapy regimens have been used for PMBL, including rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP); rituximab, methotrexate, leucovorin, doxorubicin, cycloph
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 20:20
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
嘉善县| 行唐县| 西贡区| 盐津县| 理塘县| 乳山市| 大庆市| 中宁县| 琼中| 云梦县| 星座| 平原县| 施甸县| 介休市| 锡林浩特市| 平谷区| 丹巴县| 迭部县| 尼木县| 同仁县| 兴仁县| 西安市| 拉萨市| 独山县| 孟州市| 喀什市| 含山县| 武冈市| 宜川县| 桃园县| 开封县| 滨州市| 繁昌县| 西吉县| 都兰县| 上杭县| 五台县| 左贡县| 西华县| 泗洪县| 都安|